{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:01:09Z","timestamp":1792555269707,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.msard.2023.104992","type":"journal-article","created":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T22:00:50Z","timestamp":1693778450000},"page":"104992","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Tumefactive demyelinating lesions versus CNS neoplasms, a comparative study"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4697-5415","authenticated-orcid":false,"given":"Sin Hong","family":"Chew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hairuddin Bin","family":"Achmad Sankala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Hanif bin","family":"Md Arif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norzaini Rose","family":"Mohd Zain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilwati","family":"Hashim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahedah Binti","family":"Koya Kutty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Chuan","family":"Chee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naimah Binti","family":"Mohd Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beng Hooi","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanthi","family":"Viswanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2023.104992_bib0001","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1212\/WNL.0b013e3182574f66","article-title":"Diffusion-weighted imaging characteristics of biopsy-proven demyelinating brain lesions","volume":"78","author":"Abou Zeid","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2023.104992_bib0002","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.msard.2017.04.003","article-title":"Tumefactive demyelinating lesions: a comprehensive review","volume":"14","author":"Algahtani","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2023.104992_bib0003","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1177\/1352458512438237","article-title":"Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study","volume":"18","author":"Altintas","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2023.104992_bib0004","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/bpa.12496","article-title":"Diagnostic red flags: steroid-treated malignant CNS lymphoma mimicking autoimmune inflammatory demyelination","volume":"28","author":"Barrantes-Freer","year":"2018","journal-title":"Brain Pathol."},{"key":"10.1016\/j.msard.2023.104992_bib0005","doi-asserted-by":"crossref","first-page":"199","DOI":"10.25259\/SNI_901_2020","article-title":"Tumefactive multiple sclerosis versus high-grade glioma: a diagnostic dilemma","volume":"12","author":"French","year":"2021","journal-title":"Surg. Neurol. Int."},{"key":"10.1016\/j.msard.2023.104992_bib0006","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/jnnp-2012-304498","article-title":"Tumefactive demyelination: an approach to diagnosis and management","volume":"84","author":"Hardy","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2023.104992_bib0007","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3174\/ajnr.A5089","article-title":"Combining diffusion tensor metrics and DSC perfusion imaging: can it improve the diagnostic accuracy in differentiating tumefactive demyelination from high-grade glioma?","volume":"38","author":"Hiremath","year":"2017","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.msard.2023.104992_bib0008","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jns.2015.08.034","article-title":"Tumefactive demyelinating lesions as a first clinical event: clinical, imaging, and follow-up observations","volume":"358","author":"Jeong","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2023.104992_bib0009","first-page":"563","article-title":"The variable MR appearance of primary lymphoma of the central nervous system: comparison with histopathologic features","volume":"18","author":"Johnson","year":"1997","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.msard.2023.104992_bib0010","first-page":"1362","article-title":"Bal\u00f3's concentric sclerosis: clinical and radiologic features of five cases","volume":"22","author":"Karaarslan","year":"2001","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.msard.2023.104992_bib0011","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.msard.2018.10.012","article-title":"Aphasic status epilepticus preceding tumefactive left hemisphere lesion in anti-MOG antibody associated disease","volume":"27","author":"Katsuse","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2023.104992_bib0012","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1007\/s00415-014-7437-1","article-title":"Gadolinium enhancement patterns of tumefactive demyelinating lesions: correlations with brain biopsy findings and pathophysiology","volume":"261","author":"Kobayashi","year":"2014","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2023.104992_bib0013","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12883-016-0596-1","article-title":"Demyelination as a harbinger of lymphoma: a case report and review of primary central nervous system lymphoma preceded by multifocal sentinel demyelination","volume":"16","author":"Kvarta","year":"2016","journal-title":"BMC Neurol."},{"key":"10.1016\/j.msard.2023.104992_bib0014","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1212\/CPJ.0000000000000319","article-title":"Clinicoradiologic features distinguish tumefactive multiple sclerosis from CNS neoplasms","volume":"7","author":"Lin","year":"2017","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.msard.2023.104992_bib0015","first-page":"e15","article-title":"Comparison of the features of MRI of tumefactive demyelinating lesions and glioma","volume":"357","author":"Liu","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2023.104992_bib0016","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/brain\/awn098","article-title":"Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis","volume":"131","author":"Lucchinetti","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.msard.2023.104992_bib0017","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1177\/1971400916665385","article-title":"Is size an essential criterion to define tumefactive plaque? MR features and clinical correlation in multiple sclerosis","volume":"29","author":"Patriarca","year":"2016","journal-title":"Neuroradiol. J."},{"key":"10.1016\/j.msard.2023.104992_bib0018","doi-asserted-by":"crossref","first-page":"239","DOI":"10.23736\/S1824-4785.18.03086-8","article-title":"Conventional and advanced magnetic resonance imaging in patients with high-grade glioma","volume":"62","author":"Pope","year":"2018","journal-title":"Q. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.msard.2023.104992_bib0019","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00234-005-0024-5","article-title":"Pattern of T2 hypointensity associated with ring-enhancing brain lesions can help to differentiate pathology","volume":"48","author":"Schwartz","year":"2006","journal-title":"Neuroradiology"},{"key":"10.1016\/j.msard.2023.104992_bib0020","first-page":"455","article-title":"Standardized MR imaging protocol for multiple sclerosis: consortium of MS Centers consensus guidelines","volume":"27","author":"Simon","year":"2006","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.msard.2023.104992_bib0021","article-title":"Neuroimaging and clinicopathological differences between tumefactive demyelinating lesions and sentinel lesions of primary central nervous system lymphoma","volume":"13","author":"Sun","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2023.104992_bib0022","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jns.2015.12.021","article-title":"Tumefactive demyelinating brain lesions with multiple closed-ring enhancement in the course of neuromyelitis optica","volume":"361","author":"Tomizawa","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2023.104992_bib0023","doi-asserted-by":"crossref","DOI":"10.1177\/17562864211006503","article-title":"Clinico-radiologic features and therapeutic strategies in tumefactive demyelination: a retrospective analysis of 50 consecutive cases","volume":"14","author":"Vakrakou","year":"2021","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.msard.2023.104992_bib0024","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1177\/0883073813500713","article-title":"Clinical and magnetic resonance imaging (MRI) distinctions between tumefactive demyelination and brain tumors in children","volume":"29","author":"Yiu","year":"2014","journal-title":"J. Child Neurol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823004935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823004935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T16:04:07Z","timestamp":1727453047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034823004935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":24,"alternative-id":["S2211034823004935"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2023.104992","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumefactive demyelinating lesions versus CNS neoplasms, a comparative study","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2023.104992","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104992"}}